he was diagnosed with osteosarcoma, type of bone cancer in his leg. he was an athlete and he noticed the pain, they went in and got a diagnosis. the dr. said that, the best available treatment for you is not available in the united states. you're going to to need to go overseas. so he and his family moved to england for almost one year in order to get the treatment that saved his life. that drug is called knee pack. it has been the standard of care in europe for some time and another two dozen countries, when they tried to get that same drug approved in the united states, even after it was the standard of care and all of the test showing it had come out all over the world, the fda demanded that the company test on 900 people in its clinical trial. we'll 900 patients, that's more patients than will be diagnosed with this disease in a year for this particular type. so sometimes the fda, they're just not willing to look at avatar evidence, they come they come up with things that are insurmountable barriers of trying to get these things approved. so here

of 900 patients, that is more than would be diagnosed with osteosarcoma for this particular type. so they are not going to look at other evidence and they come up with things that are insurmountable barriers to try to get these things approved. so here you have something that is a standard of care and his life-saving and the only people in the united states that can access it today can afford to go abroad and i think that we all know patients that can't afford to travel are few and far between. >> host: they say that these given the way of collecting data and some pharmaceutical companies can be a little bit nervous about providing these drugs because whatever adverse effects occur have to be reported to the fda. and as you mentioned earlier, clinical trials are concerned to be scope controlled and who gets to appear in the clinical trials. with some of your responses to concerns like that? >> all of these have been worked out in europe. we don't have to re-create the wheel. we can take some lessons that have been learned and apply them here. one of the things i think physicians a